What You Need to Know to Protect Yourself from Coronavirus (COVID-19) | Holtorf Medical Group
New patients:
Book a new patient appointment!

We've helped thousands get their life back. We can help you too!

What You Need to Know to Protect Yourself from Coronavirus (COVID-19)

What You Need to Know to Protect Yourself from Coronavirus (COVID-19)

A newly discovered strain of coronavirus, COVID-19, has recently reached a global level of infection. Unsurprisingly, the outbreak has caused a great deal of concern.

Read on to learn about COVID-19, testing practices, and effective preventative and treatment methods that you can employ to help protect yourself and others.

What is Coronavirus Disease 19 (COVID-19)?

COVID-19 is a novel strain of coronavirus that was first detected in Wuhan City, Hubei Province, China. Although many refer to COVID-19 as simply coronavirus, the term coronavirus actually describes a much broader collection of viruses. Coronaviruses have distinct crown-like spikes on their surface and carry genetic material in single strands of RNA rather than DNA. Viruses in this category are responsible for many illnesses that cause upper-respiratory problems as well as conditions like the common cold.

Most forms of coronavirus cause mild illness, but some are capable of causing serious dysfunction. Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS) are two particularly dangerous forms of coronavirus, both of which had a significant effect on world health. Although the outbreak of COVID-19 has not yet reached the same severity, it has already had an impact on global wellness.

How Does COVID-19 Spread?

COVID-19 appears to be moving steadily via community spread. Below is what we currently know regarding the spread and transference of COVID-19.

  • It is believed that the first human case of COVID-19 was caused by contact with an infected animal. It is now confirmed that person-to-person transference is also possible. 
  • COVID-19 is spread between individuals primarily through respiratory droplets expelled from the mouth. As such, coughing, sneezing, or standing in close proximity to one another can increase spread. 
  • At present, there is no evidence to indicate that COVID-19 transmission is associated with food products or packaging that is shipped over a period of days or weeks and kept at refrigerated or frozen temperatures. 
  • COVID-19 may be acquired through touching a surface or object carrying the virus and subsequent touching of the mouth, nose, or eyes. However, this is not the primary method of spread.

Symptoms of COVID-19

Currently, reported symptoms of COVID-19 include mild to severe respiratory issues accompanied by fever, cough, and difficulty breathing. If you are experiencing these symptoms, have visited or live in an area with ongoing COVID-19 spread, or have come in contact with a person known to have COVID-19 contact your healthcare professional. The CDC recommends any diagnosed individuals isolate themselves in their home or at a hospital depending on the severity of their symptoms.

Current Testing Methods for COVID-19

There are multiple testing options currently available for COVID-19. The primary mode of assessment is through identification of proteins specific to COVID-19. For example, the Stanford Health Care Clinical Virology Laboratory has developed a test that scans for a viral RNA encoding proteins and gene encoding protein indicative of COVID-19.

Another test, created by the CDC, goes a step further by testing for a third gene encoding protein found in COVID-19. Employing multiple tests such as these that target different viral-specific elements significantly increases the speed and accuracy of diagnosis.

COVID-19 test results are typically returned within 12-24 hours. A negative result indicates that the virus responsible for COVID-19 was not found in the patient’s sample. However, this does not clear the patient entirely as the virus may be missed during the early stages of infection. If a person experiencing symptoms similar to COVID-19 gets a negative test result it is likely that their symptoms are not being caused by infection of COVID-19.

Safety Practices to Prevent the Spread of COVID-19

The best way to reduce the risk of COVID-19 infection is to limit exposure and employ effective preventative practices. Below are several ways to help limit the spread of COVID-19.

  • Wash your hands thoroughly for 20 seconds after blowing your nose, coughing, sneezing, using the restroom, or being in a public space. If soap and water are not readily available, use hand sanitizer containing at least 60% alcohol.
  • Avoid close physical contact with sick individuals.
  • Remain at least six feet apart from other people.
  • Cover your mouth and nose with a tissue or inside of the elbow when sneezing or coughing.
  • Only if you are sick should you wear a face mask around others. Face masks are not needed for those who are well unless they are actively treating or caring for a sick individual.
  • On a daily basis, clean and disinfect frequently touched surfaces, such as tables, doorknobs, light switches, counter tops, desks, phones, toilets, sinks, etc. 

Employing these preventative measures not only safeguards you from infection but also helps protect those with greater risk of infection.

Who is At Risk of Infection?

Anyone exposed to a person or persons infected with COVID-19 is at risk of contracting the virus. However, certain individuals have increased likelihood of being infected and experiencing more serious complications. Older adults, persons with severe underlying chronic health issues, and people with suppressed immunity should take additional precautions to avoid infection. This includes but is not limited to foregoing group events or large gatherings, limiting physical contact with others, and staying home as much as possible if an outbreak develops in their community.

How to Proactively Combat COVID-19

Despite there not yet being a cure for COVID-19, there is still much you can do to protect yourself from it and limit its symptoms. Supplementation and peptide therapies have been shown to notably improve immune function and support the body’s ability to eliminate viral infections similar to COVID-19.

Below are several supplements and therapies that may help combat infectious viruses such as COVID-19.


There are many supplements on the market today that have proven to be effective at treating a wide range of infections. Studies suggest that the following products may also aid in the resolution of respiratory viruses such as COVID-19.

  • ImmunoStim is a supplemental product that supports illness prevention and the elimination of extant infections. It does this by increasing natural killer cell (NKC) prevalence and activity. Increasing NKC values encourages the elimination of already established infections and reduces the likelihood of future infection. ImmunoStim is most beneficial to individuals who have a higher risk of illness or wish to take preventative measures against potential sickness. 
  • Virunex is a supplemental product formulated to help combat chronic viral infections. Virunex employs powerful ingredients including glycyrrhizin (GL) and glycyrrhizic acid (GA) in the form of licorice root extract. Studies consistently show that licorice is effective against a wide range of infectious agents. In fact, many viruses that share qualities with COVID-19 have been successfully treated with licorice root.
  • Colloidal silver has been used for many years as an effective antibacterial medication. Studies show that colloidal silver effectively treats respiratory conditions including sinusitis, sinus infections, and asthma. This suggests that colloidal silver may also ease symptoms and encourage the resolution of COVID-19. 

As with all supplements, excessive or improper use can be dangerous. Therefore, speak to your doctor before beginning any new supplement regimen.

Peptide Therapies

Peptides are small chains of amino acids that may be used to improve a wide range of wellness factors. Research suggests that peptides may be particularly beneficial for reducing inflammation and destroying microbes that cause viral infections. Appropriate therapeutic application of the following peptides may even support prevention and treatment of COVID-19.

  • Thymosin Alpha-1 (TA1) is a bioidentical section of a natural peptide that supports natural killer cell activity as well as increasing antioxidant and glutathione production. Studies show that TA1 therapies effectively treat immune deficiency, viral illnesses, and bacterial infection. 
  • Thymosin Beta-4 (TB4) is a peptide found in nearly every cell in the body with exceptional tissue permeating ability. Therapies with TB4 are recognized for their accelerated patient outcomes including reduction in pain and inflammation, improved energy level, greater antioxidant and glutathione production, restoring immune function, and increasing antimicrobial activity. 
  • LL-37 is an antimicrobial and immune modulating peptide that is naturally present in the body’s innate immune system. Treatment with LL-37 provides antimicrobial and antiviral support while also improving the body’s immune and inflammatory response. It is also recognized for its ability to combat a wide range of viruses. 
  • Selank is a tetrapeptide derivative best known for supporting the central nervous system. However, studies show that selank also has immune-regulating qualities specifically relating to Th1, Th2, and Treg immune activity. Better management of these systems facilitates greater response to viruses and other forms of illness. 
  • Body protection compound-157 (BPC-157) is a synthetic peptide best known for improving healing and regeneration. Studies suggest that taking BPC-157 in conjunction with TB4 supports various factors of immunity including gut health, intestinal strength, and inflammation regulation. 

Speak to your doctor about which peptide or combination of peptide therapies are best for you.

Keep Coronavirus at Bay 

The outbreak of COVID-19 has already had a notable impact on global health and is continuing to spread in many communities worldwide. Fortunately, you can limit your risk of contracting and spreading coronavirus by employing the safety practices discussed above. You can further combat COVID-19 by appropriately supplementing with immune-boosting substances and utilizing powerful peptide therapies. Protect yourself and others by being proactive in the prevention of coronavirus. 

At Holtorf Medical Group, our physicians are experts in peptide therapies and utilizing innovative treatments to strengthen your immune system. Give us a call at 877-508-1177 to learn about our peptide and immune supporting therapies, and see how we can help you!


1. CDC. “Coronavirus Disease 2019 (COVID-19): Frequently Asked Questions.” Center for Disease Control and Prevention.
2. Stier, Heike et al. “Immune-modulatory effects of dietary Yeast Beta-1,3/1,6-D-glucan.” Nutrition journal vol. 13 38. 28 Apr. 2014.
3. D. Markin, L. Duek, I. Berdicevsky. “In vitro antimicrobial activity of olive leaves. Antimikrobielle Wirksamkeit von Olivenblättern in vitro.” DOI: 10.1046/j.1439-0507.2003.00859.x
4. Liu, Yanhong et al. “Assessment of the Antimicrobial Activity of Olive Leaf Extract Against Foodborne Bacterial Pathogens.” Frontiers in microbiology vol. 8 113. 2 Feb. 2017.
5. Somerville, Vaughan et al. “The Effect of Olive Leaf Extract on Upper Respiratory Illness in High School Athletes: A Randomised Control Trial.” Nutrients vol. 11,2 358. 9 Feb. 2019.
6. Gregory S. Kelly, N.D. “Larch Arabinogalactan: Clinical Relevance of a Novel Immune-Enhancing Polysaccharide.” Altern Med Rev. 1999 Apr;4(2):96-103.
7. Dion, Carine et al. “Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials.” Nutrition & metabolism vol. 13 28. 12 Apr. 2016.
8. Guggenheim, Alena G et al. “Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology.” Integrative medicine (Encinitas, Calif.) vol. 13,1 (2014): 32-44.
9. Vetvicka, Vaclav, and Jana Vetvickova. “Immune-enhancing effects of Maitake (Grifola frondosa) and Shiitake (Lentinula edodes) extracts.” Annals of translational medicine vol. 2,2 (2014): 14.
10. Liqiang Wang et al. “The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb.” Acta Pharm Sin B. 2015 Jul; 5(4): 310–315.
11. Yoshihiro Matsumoto et al. “Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro.” PLoS One. 2013; 8(7): e68992.
12. Ram A et al. “Glycyrrhizin alleviates experimental allergic asthma in mice.” Int Immunopharmacol. 2006 Sep;6(9):1468-77.
13. Fereshteh Sedighinia et al. “Antibacterial activity of Glycyrrhiza glabra against oral pathogens: an in vitro study.” Avicenna J Phytomed. 2012 Summer; 2(3): 118–124.
14. Morrill K et al. “Spectrum of antimicrobial activity associated with ionic colloidal silver.” J Altern Complement Med. 2013 Mar;19(3):224-31.
15. Humberto H Lara et al. “Mode of antiviral action of silver nanoparticles against HIV-1.” J Nanobiotechnology. 2010; 8: 1.
16. Swapnil Gaikwad et al. “Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3.” Int J Nanomedicine. 2013; 8: 4303–4314.
17. Damiani V et al. “Efficacy of a new medical device based on colloidal silver and carbossimetyl beta glucan in treatment of upper airways disease in children.” Minerva Pediatr. 2011 Oct;63(5):347-54.
18. Xiang DX, Chen Q, Pang L, Zheng CL. “Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro.” J Virol Methods. 2011 Dec;178(1-2):137-42.
19. SungJun Park et al. “Antiviral Properties of Silver Nanoparticles on a Magnetic Hybrid Colloid.” Appl Environ Microbiol. 2014 Apr; 80(8): 2343–2350.
20. Ershov FI et al. “Antiviral activity of immunomodulator Selank in experimental influenza infection.” Vopr Virusol. 2009 Sep-Oct;54(5):19-24.
21. Huang, L.C., D. Jean, R.J. Proske, et al. “Ocular surface expression and in vitro activity of antimicrobial peptides.” Current Eye Res. 2007. 32: 595–609.
22. Morozov VG, Khavinson KH. “Natural and synthetic peptides and immune dysfunction.” Int J Immunopharmac 1997;19(9/10):501-5.
23. Tuthill C, Rios I, McBeath R. “Thymosin alpha 1: past clinical experience and future promise.” Annals of the New York Academy of Sciences. 2010 May 1;1194(1):130-5.
24. McDermott AM. “The role of antimicrobial peptides at the ocular surface.” Ophthalmic research. 2009;41(2):60-75.
25. Kosikowska P, Lesner A. “Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015).” Expert Opin Ther Pat. 2016 Jun;26(6):689-702.
26. Tripathi S, Wang G, White M, Qi L, Taubenberger J, Hartshorn KL. “Antiviral activity of the human cathelicidin, LL-37, and derived peptides on seasonal and pandemic influenza A viruses.” PLoS One. 2015 Apr 24;10(4):e0124706.
27. Dale BA, Fredericks LP. “Antimicrobial peptides in the oral environment: expression and function in health and disease.” Current issues in molecular biology. 2005 Jul;7(2):119.

What You Need to Know to Protect Yourself from Coronavirus (COVID-19) was last modified: March 17th, 2020 by Holtorf Medical Group

Subscribe to our newsletter for all the latest updates